利用激酶抑制剂开发用于通过荧光显微镜对激酶进行成像的小分子工具。
Leveraging kinase inhibitors to develop small molecule tools for imaging kinases by fluorescence microscopy.
作者信息
Zhang Zijuan, Kwiatkowski Nicholas, Zeng Hong, Lim Sang Min, Gray Nathanael S, Zhang Wei, Yang Priscilla L
机构信息
Department of Chemistry, University of Massachusetts Boston, Boston, MA 02125, USA.
出版信息
Mol Biosyst. 2012 Oct;8(10):2523-6. doi: 10.1039/c2mb25099c.
Abstract
As the usage of fluorescence microscopy as a tool to study biological systems continues to grow, so does the need for additional tools that permit the selective detection of proteins of interest. Existing selective and well-characterized kinase inhibitors may be exploited to develop novel small molecule probes useful in imaging kinases by fluorescence microscopy.
摘要
随着荧光显微镜作为研究生物系统工具的应用不断增加，对能够选择性检测目标蛋白的其他工具的需求也在增加。现有的经过充分表征的选择性激酶抑制剂可用于开发通过荧光显微镜对激酶进行成像的新型小分子探针。
相似文献
1
Leveraging kinase inhibitors to develop small molecule tools for imaging kinases by fluorescence microscopy.利用激酶抑制剂开发用于通过荧光显微镜对激酶进行成像的小分子工具。
Mol Biosyst. 2012 Oct;8(10):2523-6. doi: 10.1039/c2mb25099c.
2
Bioorthogonal probes for polo-like kinase 1 imaging and quantification.用于检测和定量丝氨酸/苏氨酸激酶 polo-like kinase 1 的生物正交探针
Angew Chem Int Ed Engl. 2011 Sep 26;50(40):9378-81. doi: 10.1002/anie.201103273. Epub 2011 Aug 24.
3
Quantitative chemical proteomics reveals a Plk1 inhibitor-compromised cell death pathway in human cells.定量化学蛋白质组学揭示了人类细胞中一种Plk1抑制剂受损的细胞死亡途径。
Cell Res. 2014 Sep;24(9):1141-5. doi: 10.1038/cr.2014.86. Epub 2014 Jul 1.
4
Small-molecule inhibitors for targeting polo-like kinase 1.靶向Polo样激酶1的小分子抑制剂
Future Med Chem. 2020 Aug;12(16):1457-1460. doi: 10.4155/fmc-2020-0128. Epub 2020 Jul 8.
5
PLK1-Targeted Fluorescent Tumor Imaging with High Signal-to-Background Ratio.PLK1 靶向荧光肿瘤成像，具有高信号与背景比。
ACS Sens. 2017 Oct 27;2(10):1512-1516. doi: 10.1021/acssensors.7b00544. Epub 2017 Sep 28.
6
The Meisenheimer Complex as a Paradigm in Drug Discovery: Reversible Covalent Inhibition through C67 of the ATP Binding Site of PLK1.美森海默复合物作为药物发现的范例：通过 PLK1 的 ATP 结合位点的 C67 实现可逆共价抑制。
Cell Chem Biol. 2018 Sep 20;25(9):1107-1116.e4. doi: 10.1016/j.chembiol.2018.06.001. Epub 2018 Jul 12.
7
Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.LIM蛋白AJUBA的突变介导头颈部鳞状细胞癌对细胞周期抑制剂治疗的敏感性。
Cancer Lett. 2017 Apr 28;392:71-82. doi: 10.1016/j.canlet.2017.01.024. Epub 2017 Jan 23.
8
Polo-like kinases inhibitors. polo 样激酶抑制剂。
Curr Med Chem. 2012;19(23):3937-48. doi: 10.2174/092986712802002455.
9
Structure-based design and SAR development of novel selective polo-like kinase 1 inhibitors having the tetrahydropteridin scaffold.基于结构的设计和新型选择性 polo 样激酶 1 抑制剂的 SAR 研究，该抑制剂具有四氢喋呤骨架。
Eur J Med Chem. 2019 Dec 15;184:111769. doi: 10.1016/j.ejmech.2019.111769. Epub 2019 Oct 11.
10
Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors.设计、合成及生物评价 4,5-二氢-[1,2,4]三唑并[4,3-f]蝶啶衍生物作为新型双 PLK1/BRD4 抑制剂。
Eur J Med Chem. 2020 Apr 1;191:112152. doi: 10.1016/j.ejmech.2020.112152. Epub 2020 Feb 17.
引用本文的文献
1
Fluorescent kinase inhibitors as probes in cancer.荧光激酶抑制剂作为癌症研究中的探针
Chem Soc Rev. 2021 Sep 7;50(17):9794-9816. doi: 10.1039/d1cs00017a. Epub 2021 Jul 22.
2
A new genre of fluorescence recovery assay to evaluate polo-like kinase 1 ATP-competitive inhibitors.一种用于评估polo样激酶1 ATP竞争性抑制剂的新型荧光恢复测定法。
Anal Methods. 2020 Sep 28;12(36):4418-4421. doi: 10.1039/d0ay01223h. Epub 2020 Sep 3.
3
Kinase-templated abiotic reaction.激酶模板化非生物反应
Chem Sci. 2017 Jul 1;8(7):5119-5125. doi: 10.1039/c7sc01416c. Epub 2017 May 24.
4
BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen.通过虚拟筛选发现的一步合成BET溴结构域抑制剂
J Med Chem. 2017 Jun 22;60(12):4805-4817. doi: 10.1021/acs.jmedchem.6b01336. Epub 2017 Jun 7.
5
Paramagnetic relaxation enhancement for protein-observed F NMR as an enabling approach for efficient fragment screening.用于蛋白质观测氟核磁共振的顺磁弛豫增强作为高效片段筛选的一种可行方法。
RSC Adv. 2016;6(98):95715-95721. doi: 10.1039/C6RA21226C. Epub 2016 Sep 29.
6
Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika Virus.生物活性筛选表明南昌霉素是一种针对寨卡病毒的广谱抗病毒活性物质。
Cell Rep. 2017 Jan 17;18(3):804-815. doi: 10.1016/j.celrep.2016.12.068.
7
Protein-Observed Fluorine NMR Is a Complementary Ligand Discovery Method to H CPMG Ligand-Observed NMR.蛋白质观测氟核磁共振是一种与氢化学交换饱和转移配体观测核磁共振互补的配体发现方法。
ACS Chem Biol. 2016 Nov 18;11(11):3154-3164. doi: 10.1021/acschembio.6b00730. Epub 2016 Oct 5.
8
Fluorescent Analogue of Batimastat Enables Imaging of α-Secretase in Living Cells.巴替司他的荧光类似物可实现活细胞中α-分泌酶的成像。
ACS Chem Neurosci. 2016 Jan 20;7(1):40-5. doi: 10.1021/acschemneuro.5b00283. Epub 2015 Nov 18.
9
Dual Screening of BPTF and Brd4 Using Protein-Observed Fluorine NMR Uncovers New Bromodomain Probe Molecules.利用蛋白质观测氟核磁共振对BPTF和Brd4进行双重筛选，发现新型溴结构域探针分子。
ACS Chem Biol. 2015 Oct 16;10(10):2246-56. doi: 10.1021/acschembio.5b00483. Epub 2015 Jul 28.
10
Fluorescent visualization of Src by using dasatinib-BODIPY.使用达沙替尼-BODIPY 对Src 进行荧光可视化。
Chembiochem. 2014 Jun 16;15(9):1317-24. doi: 10.1002/cbic.201402010. Epub 2014 May 14.
本文引用的文献
1
From Plk1 to Plk5: functional evolution of polo-like kinases.从 Plk1 到 Plk5： Polo 样激酶的功能进化。
Cell Cycle. 2011 Jul 15;10(14):2255-62. doi: 10.4161/cc.10.14.16494.
2
Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function.小分子激酶抑制剂为 Mps1 的细胞周期功能提供了深入了解。
Nat Chem Biol. 2010 May;6(5):359-68. doi: 10.1038/nchembio.345. Epub 2010 Apr 11.
3
BODIPY dyes and their derivatives: syntheses and spectroscopic properties.硼二吡咯类染料及其衍生物：合成与光谱性质
Chem Rev. 2007 Nov;107(11):4891-932. doi: 10.1021/cr078381n. Epub 2007 Oct 9.
4
The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1.小分子抑制剂BI 2536揭示了对polo样激酶1有丝分裂作用的新见解。
Curr Biol. 2007 Feb 20;17(4):304-15. doi: 10.1016/j.cub.2006.12.046. Epub 2007 Feb 8.
5
BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.BI 2536，一种强效且选择性的polo样激酶1抑制剂，可在体内抑制肿瘤生长。
Curr Biol. 2007 Feb 20;17(4):316-22. doi: 10.1016/j.cub.2006.12.037. Epub 2007 Feb 8.
6
Sealed with a Kiz: How Plk1 ensures spindle pole integrity.由Kiz密封：Plk1如何确保纺锤体极的完整性。
Dev Cell. 2006 Oct;11(4):431-2. doi: 10.1016/j.devcel.2006.09.012.
7
The Plk1 target Kizuna stabilizes mitotic centrosomes to ensure spindle bipolarity.Polo样激酶1的靶点纽带蛋白可稳定有丝分裂中心体，以确保纺锤体双极性。
Nat Cell Biol. 2006 Oct;8(10):1095-101. doi: 10.1038/ncb1474. Epub 2006 Sep 17.
8
A cell-permeable, activity-based probe for protein and lipid kinases.一种用于蛋白质和脂质激酶的细胞可渗透、基于活性的探针。
J Biol Chem. 2005 Aug 12;280(32):29053-9. doi: 10.1074/jbc.M504730200. Epub 2005 Jun 22.
9
Structure and function of Polo-like kinases.Polo样激酶的结构与功能。
Oncogene. 2005 Jan 10;24(2):248-59. doi: 10.1038/sj.onc.1208280.
10
Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1.Plk1通过磷酸化并触发SCFβTrCP依赖的后期促进复合体抑制因子Emi1的降解来调控后期促进复合体的激活。
Mol Biol Cell. 2004 Dec;15(12):5623-34. doi: 10.1091/mbc.e04-07-0598. Epub 2004 Oct 6.
Zotero 插件